Liver Function Assessment - Feasibility and Dosing Study

NCT02516319 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision to discontinue product development.

Conditions

Hepatic Failure

Interventions

DRUG: ICG Dye

Sponsor

Cardiox Corporation